Table 2.
Data on surgical procedures and oncological outcome by treatment group
| LH (n = 11) | AH (n = 6) | P value | |
|---|---|---|---|
| Intra-operative laparoconversion | 1 (9%) | n.a. | n.a. |
| Operation time (min) | 122 [96–168] | 80 [70–192] | 0.03 |
| Blood loss (mL) | 200 [0–550] | 350 [300–1450] | 0.01 |
| Hospitalization (days) | 5 [4–16] | 8 [5–11] | 0.03 |
| Clinical follow-up (months) | 54 [18–80] | 64 [50–81] | 0.09 |
| Diseased after recurrence | 2 (18%) | 0 | 0.40 |
| Postoperative histology | |||
| Normal | 1 (9%) | 0 | |
| Atypical hyperplasia | 0 | 1 (17%) | |
| Endometrial carcinomaa | 10 (91%) | 5 (83%) | 0.60 |
| Postoperative radiotherapy | 3 (27%) | 3 (50%) | 0.34 |
Data shown as absolute numbers (percentage) or median [range]. p = p value for differences between groups using Fisher's exact test in cases of 2-by-2 tables, and Mann–Whitney test in cases of non-normal distributed numerical variables
AH abdominal hysterectomy, LH laparoscopic hysterectomy, n.a. not applicable
aEndometrial carcinomas were stage 1b grade 1 (2 patients), 1c grade 1, 2a grade 1, and 3a grade 1 in the AH group, and 1a grade 1, 1b grade 1 (3 patients), 1b grade 2, 1c grade 1, 1c grade 2 (2 patients), 2b grade 1 and 3a grade 2 in the LH group. All histologies showed endometroid type adenocarcinoma, except one woman in the LH group with stage 3a grade 2 mixed cell-type tumour (endometroid and serous adenocarcinoma)